CD1 Mouse Lung Microvascular Endothelial Cells

CD1 Mouse Lung Microvascular Endothelial Cells

Cat.No.: CSC-C4230X

Species: Mouse

Source: Lung

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4230X
Description
CD1 Mouse Lung Microvascular Endothelial Cells from Creative Bioarray are isolated from lung tissue of pathogen-free laboratory mice. CD1 Mouse Lung Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and are delivered frozen. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic pre-coated with secondary antibody.
Species
Mouse
Source
Lung
Recommended Medium
Complete Mouse Endothelial Cell Culture Medium
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Normal
Quality Control
CD1 Mouse Lung Microvascular Endothelial Cells are tested for expression of markers using antibody, VE-cadherin (CD144, VE-cadherin Antibody, C-19, sc6458, Santa Cruz); AF1002 (R&D System) or CD31/PECAM-1 (Purified Rat Anti-Mouse CD31, Catalog No. 553370, BD) by immunofluorescence staining or FACS. CD1 Mouse Lung Microvascular Endothelial Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Enhanced Host Neovascularization of Prevascularized Engineered Muscle Following Transplantation into Immunocompetent versus Immunocompromised Mice

Cells | DOI | Paper |

Background

This study engineered a fully murine, prevascularized three-dimensional skeletal muscle construct on PLLA/PLGA scaffolds using endothelial cells and satellite cells, then transplanted it into abdominal wall defects of immunocompetent and immunocompromised mice. Intravital imaging showed that host neovascularization was significantly greater in immunocompetent animals than in immunocompromised controls, especially 14–18 days post-implantation. Prevascularization improved vessel ingrowth, graft integration, and myogenesis in both models. The findings support autologous cell-based tissue engineering over allogeneic approaches and highlight the immune system's beneficial role in vascularizing engineered muscle.

Key Findings

The authors fabricated 3D vascularized murine muscle constructs by co-seeding murine endothelial cells and satellite cells on PLLA/PLGA scaffolds with fibrin gel, and transplanted them into immunocompetent CD1 Flk-1-GFP and immunocompromised athymic nude mice. Intravital imaging through an abdominal window tracked host vessel penetration over 18 days. At days 14 and 18, prevascularized EC+SC grafts in immunocompetent mice had significantly longer functional host vessel networks than grafts in immunocompromised mice, and in both models prevascularized grafts supported more host neovascularization than empty or SC-only scaffolds. EC+SC grafts also showed better integration, greater new myofiber formation, and less extracellular matrix deposition than controls. The study concludes that an intact immune system enhances graft neovascularization and that autologous cell-based prevascularization may be superior to allogeneic transplantation with immunosuppression.

Contribution

Creative Bioarray supplied CD1 mouse lung microvascular endothelial cells used to create the prevascularized engineered muscle constructs. These endothelial cells were co-cultured with satellite cells on PLLA/PLGA scaffolds, enabling vessel-like network formation and in vivo assessment of host neovascularization following transplantation into immunocompetent and immunocompromised mice.

Prevascularization promotes host neovascularization.
Fig. 1. Prevascularization promotes host neovascularization.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products